Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1002742
Abstract: Osteosarcoma (OS) is a primary bone cancer that is highly prevalent among adolescents and adults below the age of 20 years. The prognostic outcome of metastatic OS or relapse is extremely poor; thus, developing new… read more here.
Keywords: new diagnostic; osteosarcoma; extracellular vesicles; biomarker targeted ... See more keywords